ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Zyus Life Sciences Corporation

Zyus Life Sciences Corporation (ZYUS)

0.84
0.00
(0.00%)
마감 05 2월 6:00AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.84
매수가
0.81
매도가
0.84
거래량
-
0.00 일간 변동폭 0.00
0.70 52주 범위 1.19
market_cap
전일 종가
0.84
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
3,140
발행 주식
70,847,000
배당수익률
-
주가수익률
-1.40
주당순이익(EPS)
-0.6
매출
351k
순이익
-42.59M

Zyus Life Sciences Corporation 정보

섹터
Pharmaceutical Preparations
산업
Oil And Gas Field Expl Svcs
웹사이트
본부
Toronto, Ontario, Can
설립됨
2023
Zyus Life Sciences Corporation is listed in the Pharmaceutical Preparations sector of the TSX 벤처 거래소 with ticker ZYUS. The last closing price for Zyus Life Sciences was $0.84. Over the last year, Zyus Life Sciences shares have traded in a share price range of $ 0.70 to $ 1.19.

Zyus Life Sciences currently has 70,847,000 shares in issue. The market capitalisation of Zyus Life Sciences is $59.51 million. Zyus Life Sciences has a price to earnings ratio (PE ratio) of -1.40.

ZYUS 최신 뉴스

INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9

ZYUS Life Sciences Corporation (“ZYUS” or the “Company”) (TSXV: ZYUS) is pleased to announce that Brent Zettl, President and CEO of ZYUS, will present and host one-on-one meetings with investors...

ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management

ZYUS Receives Patent from United States Patent and Trademark Office (“USPTO”) Supporting ZYUS’ Lead Drug Candidate ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke

Dr. Clarke Joins ZYUS’ Clinical Advisory Committee, Bringing Extensive Expertise in Healthcare and Pain Management ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based...

ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research

Scott Livingstone brings extensive healthcare expertise and strategic leadership to ZYUS’ experienced team ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management

Evaluating Efficacy, Safety, and Tolerability in Patients with Moderate to Severe Cancer-Related Pain ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels

Completion of Phase 1 and Supportive Preclinical Data Will Assist in Ongoing Phase 2 Clinical Development of ZYUS’ Lead Drug Product Candidate ZYUS Life Sciences Corporation ("ZYUS" or the...

ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets

Mr. Miller brings nearly two decades of knowledge, experience and expertise to ZYUS ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company...

ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee

ZYUS Life Sciences Corporation ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based...

ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee

Mr. Brownlee brings more than 30 years of knowledge, experience and expertise to ZYUS’ Board of Directors ZYUS Life Sciences Corp. ("ZYUS" or the “Company”) (TSX-V: ZYUS), a Canadian-based life...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.011.204819277110.830.840.7814000.79714286CS
4-0.02-2.325581395350.860.940.7829300.8330371CS
120.0450.810.731400.83884393CS
26-0.06-6.666666666670.91.040.739350.85188215CS
52-0.15-15.15151515150.991.190.746580.95850409CS
156-1.66-66.42.52.50.788521.09403859CS
260-1.66-66.42.52.50.788521.09403859CS

ZYUS - Frequently Asked Questions (FAQ)

What is the current Zyus Life Sciences share price?
The current share price of Zyus Life Sciences is $ 0.84
How many Zyus Life Sciences shares are in issue?
Zyus Life Sciences has 70,847,000 shares in issue
What is the market cap of Zyus Life Sciences?
The market capitalisation of Zyus Life Sciences is CAD 59.51M
What is the 1 year trading range for Zyus Life Sciences share price?
Zyus Life Sciences has traded in the range of $ 0.70 to $ 1.19 during the past year
What is the PE ratio of Zyus Life Sciences?
The price to earnings ratio of Zyus Life Sciences is -1.4
What is the cash to sales ratio of Zyus Life Sciences?
The cash to sales ratio of Zyus Life Sciences is 168
What is the reporting currency for Zyus Life Sciences?
Zyus Life Sciences reports financial results in CAD
What is the latest annual turnover for Zyus Life Sciences?
The latest annual turnover of Zyus Life Sciences is CAD 351k
What is the latest annual profit for Zyus Life Sciences?
The latest annual profit of Zyus Life Sciences is CAD -42.59M
What is the registered address of Zyus Life Sciences?
The registered address for Zyus Life Sciences is 3400-22 ADELAIDE STREET W, TORONTO, ONTARIO, M5H 4E3
What is the Zyus Life Sciences website address?
The website address for Zyus Life Sciences is www.zyus.com
Which industry sector does Zyus Life Sciences operate in?
Zyus Life Sciences operates in the OIL AND GAS FIELD EXPL SVCS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ROCKEros Resources Corp
 0.06
(300.00%)
644.88k
NICKNickelex Resource Corporation
$ 0.01
(100.00%)
161k
TVITVI Pacific Inc
$ 0.01
(100.00%)
150k
PORPortofino Resources Inc
$ 0.01
(100.00%)
240k
FUNDKatipult Technology Corp
$ 0.01
(100.00%)
20k
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
2.18M
NZPChatham Rock Phosphate Limited
$ 0.055
(-35.29%)
9k
CCDCascadero Copper Corporation
$ 0.01
(-33.33%)
4k
HBKHighbank Resources Ltd
$ 0.01
(-33.33%)
35k
SCLTSearchlight Resources Inc
$ 0.01
(-33.33%)
242k
WGOWhite Gold Corp
$ 0.20
(17.65%)
11.26M
GPUSAlset AI Ventures Inc
$ 0.115
(15.00%)
4.47M
OMIOrosur Mining Inc
$ 0.19
(65.22%)
4.45M
BRCBlackrock Silver Corp
$ 0.355
(9.23%)
2.48M
XBOTRealbotix Corp
$ 0.48
(-4.00%)
2.41M
muee88 muee88 10 분 전
What does Murcidencel being included on this list of “High cost drugs - proposed list for 2024/25” mean?

https://www.england.nhs.uk/wp-content/uploads/2023/12/23-25NHSPS-amendment-consultation-annex.xlsx
NWBO
Werbe Werbe 15 분 전
Let's get a pr about future intentions, how we make this a $50 m cap company.  I think we can achieve that at least.
ATWT
Seminole Red Seminole Red 15 분 전
100 feet in difference is only 33 yards, thats pretty close for two vehicles in the air
DocLee DocLee 16 분 전
HI, DH. Sorry, I don't know whether anybody has contacted either NWBO or the MHRA but you could do it yourself. That would be a much easier option than trawling through tens (or even hundreds) of thousands of messages on this board that have been posted since the MHRA started its assessments. Bes
NWBO
chereb19 chereb19 17 분 전
The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t
RDGL
trader53 trader53 25 분 전
DPLS 0.00055 - ALERTING STRONG BUY!


DPLS - Company Update with CEO 2/13/2025
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175756306

DPLS 0.0006 - ALERTING STRONG BUY!
https://investorshub.advfn.com/boards/read_msg.aspx?mess
DPLS MFI
Seminole Red Seminole Red 26 분 전
cant wait to see what Bondi does her first day
trader53 trader53 27 분 전
DPLS 0.00055 - ALERTING STRONG BUY!


DPLS - Company Update with CEO 2/13/2025
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175756306

DPLS 0.0006 - ALERTING STRONG BUY!
https://investorshub.advfn.com/boards/read_msg.aspx?mess
DPLS MFI
Seminole Red Seminole Red 27 분 전
A Miami on the Mediterranean ......nice
in99flyers in99flyers 34 분 전
Shiba just flipped HBAR and TON to move up to the 15th ranked crypto by market cap. Better than #17. Let's go!
SHIBUSD
TightCoil TightCoil 42 분 전
High-Altitude Gear required for all traders
for rest of week
FNMA
carlson carlson 42 분 전
Longs are due for awesome news!!!
NBRI
threewheeler threewheeler 45 분 전
YES BIEI has been missed by most hopefully thats about to change, huge future prospects here if this all comes together, which every update has been positive that it is, load and hold time
BIEI
theswordman theswordman 45 분 전
Pancreatic cancer--FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT

https://www.globenewswire.com/news-release/2025/02/03/3019526/0/en/Alpha-Tau-Announces-FDA-Approval-of-IDE-Supplement-to-Expand-Pilot-Trial-of-Alpha-DaRT-to-Thirty-Patients-with-Pancreatic-Cancer-in-
DRTS
ducci1 ducci1 46 분 전
/GC--2887----/SI--32.92---------/GC Guru's Target--3000--3250 This Run ?
SPY
threewheeler threewheeler 47 분 전
KRTL hope to see New 52WK high many times the next few weeks
KRTL
Ikeboogie Ikeboogie 49 분 전
Trash Vietnamese stock posing as an American stock
PHIL
janice shell janice shell 57 분 전
Wow. Ivanka is even dumber than I'd realized:

https://www.youtube.com/watch?v=3sEJSZNbQWs
ducci1 ducci1 57 분 전
ES LITS's for Open---Pivot at 6033 & Fib at 6037 ??
SPY
MasterBlastr MasterBlastr 60 분 전
AMC is a zombie company, so it gets kicked around like a red-haired stepchild. You can Google up a zombie red haired stepchild and choose one that suits you, and give her a swift kick in the head.
AMC